Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $5B+, returning 11,890.2%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 11,890.16% |
Oklo (OKLO) | 134.43% |
Hims Hers Health (HIMS) | 122.3% |
AngloGold Ashanti (AU) | 100.61% |
Robinhood Markets (HOOD) | 86.09% |
Gold Fields Ltd ADR (GFI) | 83.47% |
Tempus AI, Inc Class A Common Stock (TEM) | 82.83% |
Verona Pharma PLC ADR (VRNA) | 81.53% |
Banco Santander SA ADR (SAN) | 79.76% |
NRG Energy (NRG) | 78.43% |
Harmony Gold Mining (HMY) | 77.68% |
Palantir Technologies Inc Class A Common Stock (PLTR) | 74.76% |
Xpeng (XPEV) | 69.66% |
Carvana (CVNA) | 69.46% |
Bancolombia SA ADR (CIB) | 67.99% |
Companhia Paranaense de Energia - COPEL (ELPC) | 66.74% |
Banco Bradesco SA ADR (BBD) | 66.38% |
Kinross Gold (KGC) | 66.24% |
Deutsche Bank (DB) | 65.86% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 64.88% |
Xp (XP) | 64.57% |
Korea Electric Power Corp ADR (KEP) | 61.61% |
Elbit Systems (ESLT) | 60.91% |
Ascentage Pharma Group International (AAPG) | 60.87% |
Wheaton Precious Metals (WPM) | 60.84% |
